RT-M103M

N/A

Report date: 2025/11/14 17:19:57

Base Information

Drug NameRT-M103M

Drug Alias NameRT-M103M

ClassificationRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsColorectal NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRadiomer Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesRadiomer Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsColorectal NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A